Trisenox
What Trisenox is used for
Trisenox is indicated for induction of remission, and consolidation in adult patients with: Newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (APL) (white blood cell count … (the exact criteria are in the official EMA product information).
Approved use, as published by the European Medicines Agency.
Key facts
- Brand
- Trisenox
- Active substance
- arsenic trioxide
- Disease area
- Leukemia, Promyelocytic, Acute
- Medicine group
- Antineoplastic agents
- ATC code
- L01XX27
- Marketing authorisation holder
- Teva B.V.
- Authorised in the EU since
- 2002
Official information
In India
- Arsenic trioxide: 3 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Trisenox used for?
Trisenox is indicated for induction of remission, and consolidation in adult patients with: Newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (APL) (white blood cell count … (the exact criteria are in the official EMA product information).
What is the active substance in Trisenox?
Trisenox contains arsenic trioxide.
Who makes Trisenox?
The EU marketing authorisation holder is Teva B.V..
Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, EU